Patents
Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160)
06/2002
06/04/2002US6399051 Keratin reducing agent
06/04/2002CA2022190C Thiol-terminated hydroxyamides
05/2002
05/30/2002WO2002042414A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
05/30/2002WO2002042262A2 Alkylthio- and aryl(heteroyl)thio-substituted p-phenylenediamines, their manufacture and their use in rubber
05/30/2002WO2002042261A2 PROCESS FOR PREPARING α-(3-ARYLTHIO)-ACETOPHENONES
05/30/2002WO2002042248A2 Naphthalene derivatives
05/30/2002WO2002001951A3 Optically pure(-) clethodim, compositions and methods for controlling plant growth comprising the same
05/30/2002WO2001092274A3 Naaladase inhibitors for treating retinal disorders and glaucoma
05/30/2002US20020065278 Non-imidazole aryloxyalkylamines
05/30/2002US20020065246 Useful agents in the treatment of inflammatory diseases such as asthma, arthritis, inflammatory bowel disease and neurodegenerative diseases
05/29/2002EP1209147A1 Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient
05/29/2002EP1208091A1 Benzophenones as inhibitors of reverse transcriptase
05/29/2002EP1208077A1 2-hydroxy-5-amino-biphenyl-derivatives and oxidative hair colouring agents containing said compounds
05/29/2002DE10045832A1 Verfahren zur Herstellung chiraler Verbindungen A process for preparing chiral compounds
05/29/2002CN1351588A Inhibitors of LFA-l binding to ICAMs and uses thereof
05/29/2002CN1085659C 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
05/28/2002US6395724 Multibinding inhibitors of cyclooxygenase-2
05/28/2002US6395718 Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors
05/28/2002CA2083274C The pharmacological use of certain cystine derivatives
05/23/2002WO2002040602A1 Fluorinated-photoinitiators in dual cure resins
05/23/2002WO2002040446A1 Glucagon antagonist/inverse agonist
05/23/2002WO2002040444A1 Glucagon antagonists/inverse agonists
05/23/2002US20020062045 Process for preparing diketone compounds and precursors thereto
05/23/2002US20020061887 For therapy and prophylaxis of cardiovascular diseases such as hypertension, angina pectoris, cardiac insufficiency, thromboses or atherosclerosis
05/23/2002CA2424477A1 Fluorinated-photoinitiators in dual cure resins
05/22/2002EP1207152A2 Pesticides
05/22/2002EP1206442A1 Substituted chiral allosteric hemoglobin modifiers
05/22/2002EP0729463B1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
05/22/2002EP0681575B1 Process for the preparation of Baccatin III analogs bearing new C2 and C4 functional groups
05/22/2002EP0676960B1 Cycloalkyl amine bis-aryl squalene synthase inhibitors
05/22/2002CN1350520A Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds
05/22/2002CN1350519A Reversible aqueous pH Sensitive lipidizing reagents, compositions and methods of use
05/22/2002CN1085195C Process for preparing free 'alpha'-hydroxy acids from ammonium salts thereof
05/21/2002WO2002042258A1 PREPARATION OF [4S-(4α,7α,10Aβ)]-4-AMINO-OCTAHYDRO-5-OXO-7H-PYRIDO[2,1-B][1,3]THIAZEPINE-7-CARBOXYLIC ACID, METHYL ESTER AND SALTS THEREOF VIA NOVEL DISULFIDES
05/21/2002US6391918 N-sulphonyl and N-sulphinyl phenylglycinamide
05/21/2002CA2039706C Method for preparing amino acid derivatives and therapeutical applications of same
05/16/2002WO2002038850A2 Alkylated fluorochemical oligomers and use thereof in the treatment of fibrous substrates
05/16/2002WO2002038539A2 A method of making a calcium salt of 2-hydroxy-4-(mercaptomethyl)butanoic acid
05/16/2002WO2002038530A1 Carboxylic acid type lipid
05/16/2002WO2001062668A3 Sulfur containing compounds
05/16/2002US20020058838 Substituted benzenesulfonylureas and -thioureas-processes for their preparation and their use as pharmaceuticals
05/16/2002US20020058784 Generation of preferential compound; obtain sample of diamino acid such as 2,3 diaminopropionic acid, incubate with compound with free amino group, recover urein
05/16/2002US20020058709 For therapy and prophylaxis of allergic disease of the eye, nose, skin, ear, gastrointestinal tract or lungs
05/16/2002US20020058660 For control of insect and acarid pests
05/16/2002US20020058629 S-nitrosothiols as agents for the treatment of circulatory dysfunctions
05/16/2002US20020056827 Piezoelectric element and process for production thereof
05/15/2002EP1205476A1 Process for the synthesis of N-(mercaptoacyl)-amino acids derivatives from alpha-substituted acrylic acids
05/15/2002CN1349525A Di-aryl acid derivatives as PPAR receptor ligands
05/15/2002CN1349523A Novel lipoic acid derivatives, their prepn., and pharmaceutical compositions containing them
05/15/2002CN1349519A Glucokinase activators
05/15/2002CN1349498A Alkenyl-and alkynyl-containing metalloprotease inhibitors
05/15/2002CN1349381A Sulfonamide derivatives
05/15/2002CN1084737C Substituted sulphonyl amino (thio) caronyl compounds and their use as herbicides
05/14/2002US6388127 Cyclization using dehydration agent
05/14/2002US6388123 Substituted phenyl keto enols as pesticides and herbicides
05/14/2002US6388122 Tryptase inhibitor and novel guanidino derivatives
05/14/2002US6388094 Method for making intermediates useful in synthesis of retroviral protease inhibitors
05/14/2002US6387949 Substituted urea compounds useful in pain management
05/14/2002US6387934 2-Cyano-3,5-dihydroxyhex-2-enecarboxamide derivatives
05/14/2002US6387924 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
05/14/2002CA2060815C Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochr omanes
05/14/2002CA2010542C Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes
05/10/2002WO2002036555A1 Sulfamides as gamma-secretase inhibitors
05/10/2002WO2002036554A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
05/10/2002WO2002036550A1 Organic compound having cyano group and insecticides/miticides
05/10/2002WO2002036547A1 Cyclopropanecarboxylic acid amide compounds and medicinal use thereof
05/10/2002WO2002036544A1 Method of resolving optical isomers of amino acid derivative
05/10/2002CA2425285A1 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
05/09/2002US20020055645 Process for synthesizing N-(mercaptoacyl) amino acid derivatives from alpha-substituted acrylic acids
05/09/2002US20020055631 N-acylsulfonamide apoptosis promoters
05/09/2002US20020055543 Inhibit phosphodiesterase type IV or inhibit the production of tumor necrosis factor; useful in treating diseases including asthma, arthritis, and sepsis.
05/09/2002US20020055039 Electrochemical utilization efficiency and capacity characteristics but also high reversibility of the charging/ discharging reaction
05/08/2002EP1203761A2 Calcium receptor-active compounds
05/08/2002EP1202956A1 Therapeutically and/or nutritionally enhanced derivatives of active ingredients and orally administrable compositions containing same
05/08/2002CN1348443A N-substituted-N'-substituted urea derivative and medicinal compositions containing the same
05/08/2002CN1348442A Novel sulfonamide compounds and uses thereof
05/08/2002CN1347693A Noval compound, its synthetizing process and therapeutic use
05/07/2002US6384273 Method for orthometalation of a carbocyclic aromatic derivative bearing at least an electron donor group
05/07/2002US6384236 N-(aroyl)glycine hydroxamic acid derivatives and related compounds
05/07/2002US6384075 Treating diseases in which mast cell dysfunction is involved
05/07/2002US6384063 Compound having effect of promoting neuron differentiation
05/02/2002WO2001047863A3 New herbicidal compositions
05/02/2002US20020052512 Diaminopropionic acid derivatives
05/02/2002US20020052399 In particular as inhibitors of HIV protease.
05/02/2002US20020052395 Treatment or prevention of a disorder in which the regulation of monoamine transporter function is implicated, such as premature ejaculation.
05/02/2002US20020052349 p-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents
05/02/2002EP1201663A1 Process for producing dibenzothiazepine derivatives
05/02/2002EP1201648A1 Carbamate derivatives and agricultural/horticultural bactericides
05/02/2002EP1200502A1 Amine hardener for epoxy resins
05/02/2002EP1200398A1 3-arylsulfonyl-2-(substituted methyl)propanoic acid derivates as matrix metalloproteinase inhibitors
05/02/2002EP1200395A1 Urea derivatives as inhibitors of ccr-3 receptor
05/02/2002EP0530338B1 Anisotropic organic compounds
05/02/2002DE10049484A1 Anticonvulsant, anxiolytic and especially analgesic medicaments, comprising new or known beta-thio-alpha-aminoacid compounds having strong affinity for gabapentin binding site
05/01/2002CN1347419A Pyrrolidincarbonylamino cyclic disulfides
05/01/2002CN1083688C New berbicides
04/2002
04/30/2002US6380434 Fullerene derivatives
04/30/2002US6380422 3-amino-2-mercaptobenzoic acid derivatives and processes for their preparation
04/30/2002US6380403 Illudin analogs useful as antitumor agents
04/30/2002US6380400 Dimethylthiocarbamic acid ester; viricides
04/30/2002US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds